Home / Leuprorelin / Austria
AT ATC L02AE02 · updated 2 Nov 2026
Leuprorelin shortage in Austria
Is there a Leuprorelin shortage in Austria?
Yes. As of 2 Nov 2026, 4 Leuprorelin products are reported short in Austria, the first since 5 Jun 2026. The company estimate for the return is 11 Jan 2027. Main reason: increased demand.
Also short in Canada, France, Italy, Norway. All countries.
Affected products in Austria
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| AT | Enantone Monats-Depot - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Enantone-Gyn Monats-Depot - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Trenantone - Zweikammerspritze, 1 Stück limited | Takeda Pharma Ges.m.b.H. | 5 Jun 2026 | not given | Increased demand Unzureichendes Kontingent für Österreich |
| AT | Lutrate 3-Monats-Depot 22,5 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension, 1 Stück | Genericon Pharma Ges.m.b.H. | 13 Oct 2026 | 11 Jan 2027 | Manufacturing problem Verzögerung bei der Herstellung |
Source
BASG (Austrian Federal Office for Safety in Health Care). Official list. All reported restrictions, listed per pack (PZN).